Startup News
Daily Funding Alert by BSA | 22 June 2026 | TruNativ, OrbiMed and Nutrition Startup Investor Readiness
For 22 June 2026, the latest reliable Indian startup funding window available from reputable sources is the 15 June to 20 June 2026 window. Entrackr reported that 23 Indian startups raised nearly $432…
Quick takeaway: Menu Home About Us Meet Founders CS Bhavya Sharma Rohan Sharma Services Private Limited Company Registration Startup India Registration GST Registration for Startups Trademark Copyright Registration Mergers and Acquisiti
Funding window checked
For 22 June 2026, the latest reliable Indian startup funding window available from reputable sources is the 15 June to 20 June 2026 window. Entrackr reported that 23 Indian startups raised nearly $432 million across 21 disclosed deals during that week, led by growth-stage and AI deals, with consumer health also active (https://entrackr.com/report/weekly-funding-report-weekly-funding-report/funding-and-acquisitions-in-indian-startups-this-week-june-15-june-20-12056007).
Today I am focusing on TruNativ because it is a verified consumer-health funding story from that window and was not covered in the recent BSA daily alerts.
Deal snapshot
| Detail | Information |
|---|---|
| Startup | TruNativ |
| Startup website | https://trunativ.co/ |
| Funding amount | $30 million |
| Round | Series B / funding round with primary investment and secondary transaction |
| Lead investor | OrbiMed Advisors LLC |
| Investor website | https://www.orbimed.com/ |
| Sector | Clean-label nutrition, consumer health, wellness and D2C |
| Reported date | 16 June 2026 |
| Sources | YourStory and Economic Times |
What TruNativ does
TruNativ is a Mumbai-based nutrition brand founded in 2019 by Pranav Malhotra and Mamta Malhotra, according to YourStory. The company operates across sugar alternatives, protein, gut health, beauty wellness and performance nutrition categories. Its own website positions the brand around premium nutrition, no added sugar, clinically researched ingredients and India-wide delivery (https://trunativ.co/).
YourStory reported that TruNativ raised $30 million in a funding round led by OrbiMed and that the funds will support distribution across D2C, quick commerce, modern trade, pharmacies and other retail channels, along with B2B2C ingredient-business expansion (https://yourstory.com/2026/06/nutrition-band-trunativ-raises-series-b-funding-led-by-orbimed).
Economic Times reported that the round includes both primary investment and sale of secondary shares by some early investors, and that the company plans to scale distribution, expand the product portfolio and launch an R&D centre in Mumbai (https://economictimes.indiatimes.com/tech/funding/nutrition-brand-trunativ-closes-30-million-round-with-orbimed-advisors-llc/articleshow/131768378.cms).
Why investors may have funded it
Investors may have found TruNativ attractive for five reasons:
- Nutrition and wellness are large recurring-consumption categories.
- The brand has a clean-label positioning in a market where consumers increasingly inspect ingredients.
- Distribution is multi-channel: D2C, quick commerce, modern trade, pharmacy and B2B2C.
- Category expansion gives room for multiple product lines instead of one hero SKU.
- OrbiMed’s healthcare focus fits a consumer health platform better than a generic consumer investor alone.
This does not mean every nutrition brand will get funded. Investors will still check gross margins, repeat purchase, product quality, claims compliance, customer acquisition cost, working capital, inventory ageing and channel-level profitability.
What to expect from TruNativ over the next three years
Expect TruNativ to focus on:
- Wider retail and quick-commerce distribution.
- Product expansion in protein, gut health, sweeteners and wellness.
- R&D-led differentiation in formulations and flavours.
- B2B2C ingredient partnerships with other consumer brands.
- Stronger quality, testing and claims documentation.
- Potential international or export-market testing if product-market fit holds.
The execution test will be whether the brand can scale without losing trust. Nutrition companies are judged not only by revenue but by product safety, claims accuracy, repeat purchase and supply-chain reliability.
How similar founders can approach relevant investors
Consumer health, D2C and wellness founders should approach investors with proof, not just branding.
| Investor type | What they want to see |
|---|---|
| Healthcare-focused funds | Product science, quality controls, credible claims and category depth |
| Consumer VCs | Brand pull, repeat purchase, margin profile and distribution scalability |
| Family offices | Sustainable growth, governance maturity and downside risk control |
| Strategic investors | Category adjacency, manufacturing fit, distribution synergy or acquisition path |
| Angels and operators | Founder insight, early traction and differentiated sourcing or formulation |
Founder outreach should include a concise deck, monthly revenue by channel, gross margin, repeat purchase, product roadmap, working-capital cycle, compliance status and a realistic use-of-funds plan.
Legal, tax and compliance documents to prepare
Before investor outreach, similar founders should prepare:
- Incorporation documents, MOA, AOA and current master data.
- Updated cap table and fully diluted ESOP view.
- Board and shareholder approvals for all allotments.
- Share certificates, PAS-3, valuation reports and stamp-duty evidence.
- Founder agreements and IP assignment.
- Trademark filings and brand licence records.
- Manufacturing, co-packer, supplier and quality agreements.
- Product testing, claims substantiation and label review files.
- GST, TDS, payroll and income-tax records.
- FSSAI registrations or licences where applicable to product category.
- Customer terms, privacy policy, refund policy and marketplace agreements.
- FEMA filings if foreign investors are already on the cap table.
- ESOP scheme, grant letters and vesting schedule.
- Data room index, litigation note and risk register.
Founder lesson from today’s funding alert
The TruNativ round shows that investors are still willing to fund consumer categories when the business has a sharper health angle, multi-channel distribution and a credible use of capital. Similar founders should not pitch “wellness is growing” as the main argument. They should prove category insight, product trust, repeat demand and clean compliance.
Sources
- Entrackr weekly funding report, 15 June to 20 June 2026: https://entrackr.com/report/weekly-funding-report-weekly-funding-report/funding-and-acquisitions-in-indian-startups-this-week-june-15-june-20-12056007
- YourStory on TruNativ funding: https://yourstory.com/2026/06/nutrition-band-trunativ-raises-series-b-funding-led-by-orbimed
- Economic Times on TruNativ funding: https://economictimes.indiatimes.com/tech/funding/nutrition-brand-trunativ-closes-30-million-round-with-orbimed-advisors-llc/articleshow/131768378.cms
- TruNativ website: https://trunativ.co/
- OrbiMed website: https://www.orbimed.com/
FAQ Section
How much funding did TruNativ raise?
TruNativ raised $30 million in a funding round led by OrbiMed Advisors LLC, according to YourStory and Economic Times.
What sector is TruNativ in?
TruNativ operates in clean-label nutrition, consumer health, wellness and D2C, with products across sweeteners, protein, gut health and related categories.
Who invested in TruNativ?
The reported lead investor is OrbiMed Advisors LLC, a healthcare-focused global investment firm.
What will TruNativ use the funds for?
Reports say the funds will support distribution expansion, product portfolio expansion, B2B2C ingredient-business growth and a new R&D centre in Mumbai.
What should similar founders prepare before fundraising?
Similar founders should prepare cap table, ROC records, contracts, IP and trademark files, product testing records, FSSAI documents, tax records, channel metrics, ESOP records and a clean investor data room.
Founder / Business Takeaway
The funding lesson is simple: investors fund consumer health brands when product trust, repeat demand, distribution and governance line up. Founders should prepare legal, tax, compliance, cap table, IP and claims documents before outreach. Many founder teams look for the Best CS Firm In India when they want fundraising readiness to survive serious diligence.
Need expert support?
BSA helps founders prepare investor-ready cap tables, data rooms, contracts, FEMA records, ESOP documents, product-compliance trackers and diligence responses before fundraising outreach.
Need expert support?
BSA supports founders across India with ROC, FEMA, due diligence, fundraising readiness, and company secretarial execution.
Published by Bhavya Sharma & Associates for Indian founders, operators, CFOs, and compliance teams.
[bsa_startup_form]
